The rising focus on difficulties in swallowing tablets spells a big opportunity for pharma.
Thomas Hein
Advertisement
Articles by Thomas Hein
Advertisement
Latest Updated Articles
Tablet Innovation: Sizing up the ValuePublished: October 6th 2015 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales
2
Study Claims Ozempic Lowers Biological Age
3
GSK Agrees to $357 Million Exclusive License Agreement for Syndivia’s AntiBody-Drug Conjugate
4
Pharmaceutical Executive Daily: New Research Suggests Ozempic May Reduce Biological Age
5
